Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRI vs Docetaxel and Cisplatin in Advanced Gastric Cancer
NCT03067792Phase 3Completed
- Sponsor
- Yonsei University
- Start
- Dec 2014
- Primary completion
- Oct 2016
- Modality
- Nanoparticles, Small Molecules
01
Overview
A Phase 3 trial of docetaxel, Cisplatin micelle injection (HA132) in gastric cancer (GC), sponsored by Yonsei University. Started Dec 2014; status: completed.
02
Drugs
docetaxelCisplatin micelle injection (HA132)
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03067792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067792.